Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results
10 août 2021 16h05 HE
|
Interpace Biosciences, Inc.
●Q2 Revenue of $11.2 Million Surpasses Q1 2021 as Company’s Highest Revenue Quarter ●Company approaching EBITDA breakeven on Higher Clinical Volume, Revenue, Improved Gross Profit and Operating...